| Literature DB >> 27453284 |
Ivan Baltadzhiev1, Nedialka Popivanova2, Zaprian Zaprianov3.
Abstract
Entities:
Mesh:
Year: 2016 PMID: 27453284 PMCID: PMC9425533 DOI: 10.1016/j.bjid.2016.06.002
Source DB: PubMed Journal: Braz J Infect Dis ISSN: 1413-8670 Impact factor: 3.257
Mediterranean spotted fever malignant forms: risk factors for fatal outcomes.
| Indicators | MSF lethal cases | MSF survivors | Two tailed | Odds ratio | 95% CI |
|---|---|---|---|---|---|
| Fisher's exact test | |||||
| Age >45 years | 17/19 | 16/36 | =0.001 | 10.625 | 2.13–52.95 |
| More than 6 days to hospital admission | 17/19 | 12/36 | <0.0001 | 17.00 | 3.36–86.03 |
| Pre-morbid underlying conditions | 15/19 | 2/36 | <0.0001 | 63.75 | 10.5–386.9 |
| Tick bite (Tache noire) | 17/19 | 24/36 | =0.103 | 4.250 | 0.84–21.50 |
| Sever disturbances in acid–base balance | 13/19 | 4/36 | <0.0001 | 17.333 | 4.19–71.73 |
| Failure to start or to complete appropriate antibiotic treatment | 11/19 | 4/36 | =0.0004 | 11.00 | 2.76–43.82 |
| Lung involvement (interstitial pneumonia) | 13/19 | 16/36 | =0.15 | 2.708 | 0.84–8.725 |
| Acute renal failure | 16/19 | 14/36 | =0.001 | 8.381 | 2.06–34.12 |
| Gastrointestinal bleeding | 6/19 | 2/36 | =0.01 | 7.846 | 1.40–43.97 |
| Liver involvement (ALT/AST high levels) | 16/19 | 35/36 | =0.11 | 0.152 | 0.014–1.58 |
| Liver involvement (Jaundice) | 11/19 | 24/36 | =0.58 | 0.687 | 0.218–2.16 |
| Pancreatic involvement | 4/19 | 1/36 | =0.04 | 9.333 | 0.96–90.69 |
| Myocardial involvement | 8/19 | 8/36 | =0.210 | 2.545 | 0.76–8.478 |
| CNS involvement: (Mental confusion – “Typhus state”) | 19/19 | 30/36 | =0.08 | 1.719 | 0.558–5.29 |
| CNS involvement: Encephalitis (delirium, seizures, stupor, coma) | 12/19 | 12/36 | =0.04 | 3.429 | 1.07–10.96 |
CI, confidence interval; MSF, Mediterranean spotted fever.